Inhibition of the miR-200b-200a-429 promoter by ZEB2 was rescued by TBX1 in a dose-dependent manner in these cells (Fig. 3K), but not in MCF7 breast cancer cells (Supplementary data, Fig. S5). Here, ZEB2 is linked to breast carcinoma.